Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Immune Activation in HIV-1 Patients on ART (CESAR)
NCT01874743Phase 2Unknown
- Start
- Mar 2012
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in human immunodeficiency virus type 1 infection (HIV-1). Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01874743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874743.